STEK — Stemtech Corp

OTC · Consumer Discretionary · Distributors · CIK 1511820 ·
Last close
$0.00
Market Cap
$413.6K
52W High
$0.00
52W Low
$0.00
ADV30
16,150,598
Next earnings
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers rapid renewed stem cell peptide night cream under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, and Collect One brand name, as well as Cellect One shield hypochlorous acid skin care product. It sells products through independent distributors. Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 458,109 354,677 -863,937 -1,482,293 3,149,614 238,245 10,854,013
Sep 2025 852,300 682,483 -339,217 -809,406 3,755,801 255,416 10,301,779
Jun 2025 697,925 552,016 -300,988 -293,145 3,872,156 272,450 10,323,863
Mar 2025 868,046 720,264 -1,204,905 -1,455,591 3,754,250 305,836 9,437,421

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-483,583
Investing CF
$0
Financing CF
$460,010
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.03
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-34,877,757
Inventory
$217,338
Receivables
$0
ST Investments
EBIT TTM
$-2,597,690
Pretax Income TTM
$-4,049,840
Interest Exp TTM
$1,452,150
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,876,380
EBITDA
$-2,541,552
Free Cash Flow
$965,057
Enterprise Value
$4,434,851
Total Cash
$238,245
Total Debt
$5,005,267
Shares Out
2,067,960,034
Trailing EPS
$-0.02
Book Value
$-0.02
ROE
ROA
-48.9%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 2,876,380 -2,709,047 -4,046,705 3,149,614 10,854,013 -483,583
Dec 2024 5,053,690 -2,386,427 -3,769,566 3,782,245 9,009,050 -601,198
Dec 2023 4,921,531 -4,224,548 -5,430,245 3,683,271 6,462,036 -2,036,012
Dec 2022 4,559,399 -5,023,380 -8,544,923 4,266,941 7,438,859 -1,216,948
Dec 2021

Peers — same industry

TickerNameMarket CapLastDaily %
CWPE CW Petroleum Corp $448.9K $0.02
SKFG Stark Focus Group, Inc. $835.7K $0.08
DTCKF DAVIS COMMODITIES Ltd $1.03M $1.20
NASC Can B Corp $1.17M $0.01
AHRO Authentic Holdings, Inc. $1.24M $0.00

News headlines (Yahoo Finance, 1h cache)

Stemtech Secures Inventory Funding
2026-04-07 12:30 · Yahoo
Stemtech Revolution 2026: A Bold New Era In Global Wellness
2026-03-18 12:30 · Yahoo
Stemtech Corporation Launches New Market Channel Biosciences Ecommerce
2026-02-26 13:30 · Yahoo
Stemtech Corporation Welcomes Dr. Zahooruddin To Life Sciences Advisory Board
2026-02-03 13:30 · Yahoo
Stemtech Corporation Appoints Dr. Lizette Leos, MD To Chief Scientific Officer (CSO)
2026-01-06 13:30 · Yahoo
Stemtech Corporation Announces Entry into China in a Joint Venture with Lightway Ventures
2025-12-02 13:30 · Yahoo
Stemtech Corporation - Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry
2025-10-27 12:30 · Yahoo
Stemtech Corporation Announces Entry Into India in a Joint Venture With Innoventure Dynamic LLP
2025-10-23 12:30 · Yahoo
Stemtech Corporation Backorders Filled
2025-10-20 12:30 · Yahoo
Stemtech Corporation Announces Exclusive Taiwan Distribution Licensing Agreement
2025-10-09 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.